What does purchases of equity securities mean?

Cash spent purchasing equity securities for the investment portfolio.

Catalyst Pharmaceutical CPRX Purchases of equity securities

Purchases of equity securities at other companies

TG TherapeuticsTGTX

$0-100%

Other financials

Income statement

See full

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/E17.4×-1.6×

P/S6.4×-0.6×

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireEquitySecuritiesFvNi.

The official record: Catalyst Pharmaceutical’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's purchases of equity securities.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's purchases of equity securities?: Catalyst Pharmaceutical (CPRX) reported purchases of equity securities of $0 in Q4 2025.
What does purchases of equity securities mean?: Cash spent purchasing equity securities for the investment portfolio.